Search results
Results from the WOW.Com Content Network
Promising results of health and medical research are reported: researchers report an apparent substantially improved prognoses of head and neck cancers if Fusobacterium is present in the patient's oral microbiome, a common bacteria of mouths thought to make bowel cancer worse (6 July), [339] [340] phase 3-trialed lenacapavir for HIV prevention ...
The Advanced Research Projects Agency for Health (ARPA-H) is an agency within the Department of Health and Human Services. [1] Its mission is to "make pivotal investments in break-through technologies and broadly applicable platforms, capabilities, resources, and solutions that have the potential to transform important areas of medicine and health for the benefit of all patients and that ...
The WHI was created in 2009 with a $45 million grant from the West Foundation. It is an independent, medical research organization that works with healthcare providers and research institutions to lower healthcare costs and improve healthcare delivery and social services for seniors.
Creating and modifying species (mainly improving their physical and mental capabilities), bio-machines, eliminating genetic disorders (gene therapy), new materials production, [89] healthier and cheaper food, creating drugs and vaccines, research in natural sciences, bioremediation, [90] detecting arsenic, [91] CO2 reducing superplant, [92]
As of 2024, 7 people have been reported cured of AIDS by stem cell transplants, 5 of those from donors with two copies of the CCR5-delta-32 mutation which gives protection against HIV infection and these have been dubbed as the "Berlin" (2008), "London" (2020), "Duesseldorf" (2022), "New York" (2022) and "City of Hope" (2023) patients.
Past work included the proposal of improvements for automobile safety, [7] the neurosurgical introduction of a silicone plastic material that made cerebrospinal fluid shunting practical for the treatment of hydrocephalus, [8] [9] [10] advances in cardiovascular research, [11] and the development of electronic neurological devices, including ...
Katalin Karikó was born on January 17, 1955, in Szolnok, Hungary. [4] From the University of Szeged, she received a Ph.D. in biochemistry in 1982. [5] From 2013 to 2022, she was associated with BioNTech RNA Pharmaceuticals, first as a vice president and promoted to senior vice president in 2019.
The ability to incorporate drugs into nanocarriers offers a new prototype in drug delivery that could hold great promise for attaining bioavailability enhancement along with controlled and site-specific drug delivery. SLNs are also considered to well tolerated in general, due to their composition from physiologically similar lipids.